{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:28:39Z","timestamp":1791984519252,"version":"4.4.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sarcopenia, a age-related disease characterized by loss of muscle mass accompanied by loss of function, is associated with nutrition imbalance, physical inactivity, insulin resistance, inflammation, metabolic syndrome, and atherosclerosis which are risk factors for cardiovascular disease. However, its association with outcomes after ischemic stroke has not been well-established. This study investigated whether functional outcomes of patients with acute ischemic stroke is associated with sarcopenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected from 568 consecutive patients with acute ischemic stroke with National Institute of Health Stroke Scale 0\u20135 or transient ischemic attack who underwent bioelectrical impedance analysis between March 2018 and March 2021. Sarcopenia was defined, as low muscle mass, as measured by bioelectrical impedance analysis, and low muscle strength, as indicated by the Medical Research Council score. Unfavorable functional outcome was defined as mRS score of 2\u20136 at 90 days after discharge. The relationship between functional outcomes and the presence of sarcopenia or its components was determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 568 patients included (mean age 65.5 \u00b1 12.6 years, 64.6% male), sarcopenia was detected in 48 (8.5%). After adjusting for potential confounders, sarcopenia was independently and significantly associated with unfavorable functional outcome (odds ratio 2.37, 95% confidence interval 1.15\u20134.73 for unfavorable functional outcome, odds ratio 2.10, 95% confidence interval 1.18\u20133.71 for an increase in the mRS score). Each component of sarcopenia was also independently associated with unfavorable functional outcome (odds ratio 1.76, 95% confidence interval 1.05\u20132.95 with low muscle mass, odds ratio 2.64, 95% confidence interval 1.64\u20134.23 with low muscle strength). The impact of low muscle mass was larger in men than in women, and in patients with lower muscle mass of the lower extremities than in those with lower muscle mass of the upper extremities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, the prevalence of sarcopenia in patients with stroke was lower than most of previous studies and patients with sarcopenia showed higher likelihood for unfavorable functional outcomes at 90 days after acute ischemic stroke or TIA. Further investigation of the interventions for treating sarcopenia and its impact on the outcome of ischemic stroke patients is needed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.841945","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T04:51:27Z","timestamp":1647319887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Impact of Sarcopenia on Functional Outcomes Among Patients With Mild Acute Ischemic Stroke and Transient Ischemic Attack: A Retrospective Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Hyungwoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoonNyung","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoul","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Suk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/s0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1212\/WNL.0b013e318206ca1e","article-title":"Three-month stroke outcome","volume":"76","author":"Heuschmann","year":"2011","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"990s","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"110801","DOI":"10.1016\/j.exger.2019.110801","article-title":"Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis","volume":"131","author":"Pacifico","year":"2020","journal-title":"Exp Gerontol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcsm.12587","article-title":"Sarcopenia and peripheral arterial disease: a systematic review","volume":"11","author":"Pizzimenti","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/PHM.0000000000000694","article-title":"Grip strength on the unaffected side as an independent predictor of functional improvement after stroke","volume":"96","author":"Yi","year":"2017","journal-title":"Am J Phys Med Rehabil."},{"key":"B8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jocn.2019.08.109","article-title":"Can initial sarcopenia affect poststroke rehabilitation outcome?","volume":"71","author":"Jang","year":"2020","journal-title":"J Clin Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104623","article-title":"Correlation between skeletal muscle mass deficit and poor functional outcome in patients with acute ischemic stroke","volume":"29","author":"Ohyama","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.5535\/arm.2019.43.5.535","article-title":"Effect of decreased skeletal muscle index and hand grip strength on functional recovery in subacute ambulatory stroke patients","volume":"43","author":"Park","year":"2019","journal-title":"Ann Rehabil Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000510436","article-title":"Advanced liver fibrosis predicts unfavorable long-term prognosis in first-ever ischemic stroke or transient ischemic attack","volume":"49","author":"Baik","year":"2020","journal-title":"Cerebrovasc Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5535\/arm.2020.44.1.20","article-title":"Suggested assessments for sarcopenia in patients with stroke who can walk independently","volume":"44","author":"Jung","year":"2020","journal-title":"Ann Rehabil Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/mus.22219","article-title":"Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit","volume":"45","author":"Hermans","year":"2012","journal-title":"Muscle Nerve."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke."},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams HP","year":"1993","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7570\/jomes.2019.28.1.40","article-title":"2018 Korean Society for the study of obesity guideline for the management of obesity in Korea","volume":"28","author":"Seo","year":"2019","journal-title":"J Obes Metab Syndr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1747-4949.2009.00271.x","article-title":"Functional outcome measures in contemporary stroke trials","volume":"4","author":"Quinn","year":"2009","journal-title":"Int J Stroke."},{"key":"B19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/10635150490522304","article-title":"Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests","volume":"53","author":"Posada","year":"2004","journal-title":"Syst Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.apmr.2016.07.015","article-title":"Sarcopenia and physical function in middle-aged and older stroke survivors","volume":"98","author":"Ryan","year":"2017","journal-title":"Arch Phys Med Rehabil."},{"key":"B21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.clnu.2016.12.002","article-title":"Prevalence of stroke-related sarcopenia and its association with poor oral status in post-acute stroke patients: Implications for oral sarcopenia","volume":"37","author":"Shiraishi","year":"2018","journal-title":"Clin Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jcsm.12163","article-title":"Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study","volume":"8","author":"Yang","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jamda.2020.10.036","article-title":"Effect of sarcopenia status on disability incidence among Japanese older adults","volume":"22","author":"Shimada","year":"2021","journal-title":"J Am Med Direct Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1532-5415.2005.00540.x","article-title":"Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study","volume":"54","author":"Janssen","year":"2006","journal-title":"J Am Geriatr Soc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/joor.12948","article-title":"The relationship between sarcopenia and oral sarcopenia in elderly people","volume":"47","author":"Kobuchi","year":"2020","journal-title":"J Oral Rehabil."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/gerona\/glu050","article-title":"Sarcopenia: an independent predictor of mortality in community\u2013dwelling older Korean men","volume":"69","author":"Kim","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12902-019-0432-x","article-title":"Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria","volume":"19","author":"Du","year":"2019","journal-title":"BMC Endocr Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12020-013-9992-0","article-title":"Sarcopenic obesity in aging population: current status and future directions for research","volume":"45","author":"Kohara","year":"2014","journal-title":"Endocrine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2318-9-19","article-title":"A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the \u201cTreviso Longeva (TRELONG)\u201d study","volume":"9","author":"Albani","year":"2009","journal-title":"BMC Geriatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/STROKEAHA.110.582627","article-title":"Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention","volume":"41","author":"Banerjee","year":"2010","journal-title":"Stroke."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.841945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T04:51:29Z","timestamp":1647319889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.841945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":30,"alternative-id":["10.3389\/fneur.2022.841945"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.841945","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"841945"}}